Exicure Inc./$XCUR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
Ticker
$XCUR
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
7
ISIN
US30205M3097
Website
Exicure Inc. Metrics
BasicAdvanced
$37M
-
-$4.75
3.85
-
Price and volume
Market cap
$37M
Beta
3.85
52-week high
$15.91
52-week low
$5.42
Average daily volume
7K
Financial strength
Current ratio
4.452
Quick ratio
4.243
Long term debt to equity
76.979
Total debt to equity
87.64
Interest coverage (TTM)
-274.94%
Profitability
EBITDA (TTM)
-4.921
Gross margin (TTM)
100.00%
Net profit margin (TTM)
-1,940.20%
Operating margin (TTM)
-989.80%
Effective tax rate (TTM)
-0.08%
Revenue per employee (TTM)
$70,000
Management effectiveness
Return on assets (TTM)
-23.23%
Return on equity (TTM)
-197.92%
Valuation
Price to revenue (TTM)
24.07
Price to book
5.24
Price to tangible book (TTM)
5.24
Price to free cash flow (TTM)
-4.136
Free cash flow yield (TTM)
-24.18%
Free cash flow per share (TTM)
-142.42%
Growth
Earnings per share change (TTM)
-55.01%
3-year revenue growth (CAGR)
1.16%
3-year earnings per share growth (CAGR)
-64.76%
Exicure Inc. News
AllArticlesVideos
Exicure, Inc. Reports First Quarter 2025 Financial Results
Business Wire·3 days ago
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
Business Wire·1 month ago
Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma
Business Wire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Exicure Inc. stock?
Exicure Inc. (XCUR) has a market cap of $37M as of July 01, 2025.
What is the P/E ratio for Exicure Inc. stock?
The price to earnings (P/E) ratio for Exicure Inc. (XCUR) stock is 0 as of July 01, 2025.
Does Exicure Inc. stock pay dividends?
No, Exicure Inc. (XCUR) stock does not pay dividends to its shareholders as of July 01, 2025.
When is the next Exicure Inc. dividend payment date?
Exicure Inc. (XCUR) stock does not pay dividends to its shareholders.
What is the beta indicator for Exicure Inc.?
Exicure Inc. (XCUR) has a beta rating of 3.85. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.